使用依替膦酸治疗骨质疏松症期间听力进一步丧失。
Further hearing loss during osteoporosis treatment with etidronate.
作者信息
Yaşil S, Cömlekçi A, Güneri A
机构信息
Dokuz Eylül University, Medical Faculty, Inciralti, Izmir, Turkey.
出版信息
Postgrad Med J. 1998 Jun;74(872):363-4. doi: 10.1136/pgmj.74.872.363.
Abstract
Ototoxicity is a rare and disabling complication in bisphosphonate therapy. Here we describe two patients who encountered further hearing loss during oral etidronate treatment for osteoporosis.
摘要
耳毒性是双膦酸盐治疗中一种罕见且致残的并发症。在此，我们描述两名在口服依替膦酸治疗骨质疏松症期间出现进一步听力损失的患者。
相似文献
1
Further hearing loss during osteoporosis treatment with etidronate.使用依替膦酸治疗骨质疏松症期间听力进一步丧失。
Postgrad Med J. 1998 Jun;74(872):363-4. doi: 10.1136/pgmj.74.872.363.
2
The effects of etidronate disodium on progressive hearing loss from otosclerosis.依替膦酸二钠对耳硬化症所致进行性听力损失的影响。
Otolaryngol Head Neck Surg. 1993 Sep;109(3 Pt 1):461-7. doi: 10.1177/019459989310900312.
3
Etidronate for postmenopausal osteoporosis.依替膦酸二钠治疗绝经后骨质疏松症。
Med Lett Drugs Ther. 1990 Dec 14;32(833):111-2.
4
Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis.间歇性周期性使用依替膦酸治疗绝经后骨质疏松症的五年临床经验
J Rheumatol. 1996 Sep;23(9):1560-4.
5
Lower extremity stress fractures during intermittent cyclical etidronate treatment for osteoporosis.
Calcif Tissue Int. 1994 May;54(5):431-4. doi: 10.1007/BF00305532.
6
Atypical osteomalacia after 2 year etidronate intermittent cyclic administration in osteoporosis.骨质疏松症患者接受依替膦酸二钠间歇循环给药2年后出现非典型骨软化症。
J Rheumatol. 1995 Nov;22(11):2183-5.
7
Critical drug appraisal: etidronate intermittent cyclic therapy for postmenopausal osteoporosis.
Br J Clin Pract. 1996 Jan-Feb;50(1):23-31.
8
Pseudogout associated with the use of cyclical etidronate therapy.
Scott Med J. 1991 Apr;36(2):49. doi: 10.1177/003693309103600207.
9
Prolonged-efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease.双膦酸盐对绝经后骨质疏松症合并慢性肝病女性的长期疗效
J Med Virol. 2008 Jul;80(7):1302-7. doi: 10.1002/jmv.21195.
10
Treatment of postmenopausal osteoporosis with etidronate.依替膦酸治疗绝经后骨质疏松症
Ann Pharmacother. 1993 Oct;27(10):1200-1.
引用本文的文献
1
Bisphosphonate therapy in otosclerosis: A scoping review.耳硬化症的双膦酸盐治疗：一项范围综述。
Laryngoscope Investig Otolaryngol. 2022 Jan 6;7(1):242-249. doi: 10.1002/lio2.729. eCollection 2022 Feb.
2
Regeneration of Cochlear Synapses by Systemic Administration of a Bisphosphonate.通过全身给予双膦酸盐实现耳蜗突触再生
Front Mol Neurosci. 2020 Jul 14;13:87. doi: 10.3389/fnmol.2020.00087. eCollection 2020.
3
Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis.三代双膦酸盐治疗耳硬化症所致感音神经性听力损失。
Otol Neurotol. 2012 Oct;33(8):1308-14. doi: 10.1097/MAO.0b013e318268d1b3.
4
Perspectives of pharmacological treatment in otosclerosis.耳硬化症的药物治疗观点。
Eur Arch Otorhinolaryngol. 2013 Mar;270(3):793-804. doi: 10.1007/s00405-012-2126-0. Epub 2012 Jul 29.
本文引用的文献
1
Bisphosphonates: mechanisms of action and clinical use in osteoporosis--an update.
Horm Metab Res. 1997 Mar;29(3):145-50. doi: 10.1055/s-2007-979008.
2
The effects of etidronate disodium on progressive hearing loss from otosclerosis.依替膦酸二钠对耳硬化症所致进行性听力损失的影响。
Otolaryngol Head Neck Surg. 1993 Sep;109(3 Pt 1):461-7. doi: 10.1177/019459989310900312.
3
Clearance and tissue uptake following 4-hour and 24-hour infusions of pamidronate in rats.大鼠静脉输注帕米膦酸盐4小时和24小时后的清除率及组织摄取情况。
Drug Metab Dispos. 1993 Jan-Feb;21(1):100-4.
4
Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis.使用强效双膦酸盐帕米膦酸盐对绝经后骨质疏松症进行持续治疗。
J Clin Endocrinol Metab. 1994 Dec;79(6):1595-9. doi: 10.1210/jcem.79.6.7989461.
5
The therapeutic use of bisphosphonates.双膦酸盐的治疗用途。
BMJ. 1994 Sep 17;309(6956):711-5. doi: 10.1136/bmj.309.6956.711.
6
Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.环磷腺苷葡胺可逆转已确诊的糖皮质激素性骨质疏松患者脊柱和股骨近端的骨质流失。
Am J Med. 1995 Sep;99(3):235-42. doi: 10.1016/s0002-9343(99)80154-5.
7
Ototoxicity associated with intravenous bisphosphonate administration.
Calcif Tissue Int. 1995 Jun;56(6):584-5. doi: 10.1007/BF00298594.
8
Otosclerotic involvement of the cochlea: a histologic and audiologic study.
Otolaryngol Head Neck Surg. 1981 Mar-Apr;89(2):343-51. doi: 10.1177/019459988108900239.
9
Etiopathogenesis of otosclerosis: a hypothesis.耳硬化症的病因发病机制：一种假说。
Ann Otol Rhinol Laryngol. 1984 Jan-Feb;93(1 Pt 1):28-33. doi: 10.1177/000348948409300107.
10
Clinical experience with the use of two diphosphonates in the treatment of Paget's disease.使用两种双膦酸盐治疗佩吉特病的临床经验。
Ann Rheum Dis. 1985 Jan;44(1):34-8. doi: 10.1136/ard.44.1.34.
Zotero 插件